Shanghai Pharmaceuticals Holding Co Ltd SSE:601607:
SAYS IT PLANS TO RENEW FRAMEWORK AGREEMENT WITH YUNNAN BAIYAO GROUP CO LTD, WITH SALES TO YUNNAN BAIYAO CAPPED AT 1.2 BILLION YUAN ($171.21 million), PURCHASES CAPPED AT 700 MILLION YUAN FOR 2026
($1 = 7.0088 Chinese yuan renminbi)